170687 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase
MULTI-PROTEIN BIOMARKER ASSAY FOR BRAIN INJURY DETECTION AND OUTCOME
#2A Novel Chemogenetic Tool Permitting Modulation of Intracellular pH
#3BIOMARKERS
#4CA-IX TARGETING FLUORESCENT PROBES
#5BIOMARKERS OF FIBROSIS AND USES THEREFOR
#6BLADDER CANCER BIOMARKERS AND METHODS OF USE
#7METHODS FOR DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE
#8PERSONALIZED CANCER IMMUNOTHERAPY
#9METHODS OF IDENTIFYING AND/OR CHARACTERIZING A POLYNUCLEOTIDE OF INTEREST
#10APPARATUS AND METHODS USING TETHERED ENZYMES FOR THE DETECTION OF THE ENZYMATIC ACTIVITY OF BIOMARKERS
#11COMBINATORIAL HIGH-THROUGHPUT SCREENING OF COMPLEX POLYMERIC ENZYME IMMOBILIZATION SUPPORTS
#12Methods for Sample Quality Assessment
#13ORAL MESENCHYMAL STEM CELLS AND USE THEREOF
#14TARGETING NEUROPILIN 2 (NRP2) IN LETHAL PROSTATE CANCER
#15Methods and Compositions for Evaluating Biomarkers in Salivary Exosomes and Evaluating Cognitive Fatigue
#16Supermere Nanoparticles and Methods of Isolation and Use Thereof
#17ANTI-GUCY2C NANO-ANTIBODY AND APPLICATION THEREOF
#18METHOD OF DETECTING EPIGENETIC MODIFICATION
#19Biomarkers For Lysosomal Storage Diseases
#20MINIMALLY-INVASIVE MEASUREMENT OF ESOPHAGEAL INFLAMMATION
#21CAIX TARGETING IL-12 FUSION PROTEINS AND METHODS OF USE THEREOF
#22Genetically-encoded volatile synthetic biomarkers for breath-based cancer detection
#23METHOD FOR QUANTIFYING PHENYLALANINE IN BLOOD, AND MEASUREMENT KIT USED THEREFOR
#24High Sensitivity Analyte Network Detection Flow Assays And Related Methods
#25APPARATUS AND METHODS USING TETHERED ENZYMES FOR THE DETECTION OF THE ENZYMATIC ACTIVITY OF BIOMARKERS
#26Apparatus and methods using tethered enzymes for the detection of the enzymatic activity of biomarkers
#27CITRULLINATED PROTEINS AS BIOMARKERS AND THERAPY TARGETS FOR CANCER
#28CARBONIC ANHYDRASE 1 (CA1) INHIBITORS FOR THE TREATMENT OR PREVENTION OF MYELOPROLIFERATIVE DISORDERS AND OTHER HEMATOPOIETIC MALIGNANCIES, AND AS BIOMARKER OF MYELOPROLIFERATIVE DISORDERS AND OTHER HEMATOPOIETIC MALIGNANCIES
#29ANTI- ENOLASE 1 (ENO1) ANTIBODY AND APPLICATIONS THEREOF
#30METHODS FOR QUANTIFYING DRUG CONCENTRATION IN A PRODRUG COMPOSITION
#31BACTERIA ENGINEERED TO REDUCE HYPERPHENYLALANINEMIA
#32BIOMARKER COMPOSITION FOR DIAGNOSING DEGENERATIVE BRAIN DISEASES
#33Method for purifying and detecting 6-hydroxynobilonine in fresh stems of dendrobium huoshanense
#34CIRCULATING MICROVESICLES EXPRESSING CARBONIC ANHYDRASE 9 FOR THE PROGNOSIS OF RENAL CELL CARCINOMA
#35CA IX - NIR DYES AND THEIR USES
#36PEPTIDES FOR IMMUNOTHERAPY
#37Polypeptide for targeting recognition of immune cells and application thereof
#38MULTI-PROTEIN BIOMARKER ASSAY FOR BRAIN INJURY DETECTION AND OUTCOME
#39ANTIGENIC NEURON SPECIFIC ENOLASE PEPTIDES FOR DIAGNOSING AND TREATING AUTISM
#40CRYSTALLIZED OXALATE DECARBOXYLASE AND METHODS OF USE
#41METHODS TO DETERMINE WHETHER A SUBJECT IS SUITABLE OF BEING TREATED WITH AN AGONIST OF SOLUBLE GYANYLYL CYCLASE (SGC)
#42TREATMENT STRATIFICATION FOR AN EXACERBATION OF INFLAMMATION
#43MEANS AND METHOD FOR THE EARLY PREDICTION OF POOR NEUROLOGICAL OUTCOME IN OUT-OF-HOSPITAL CARDIAC ARREST SURVIVORS
#44GENETIC MARKER FOR HELICOBACTER PYLORIASSOCIATED DISEASE
#45Genetically modified bacteria producing three DNA repair enzymes and method for the evaluation of DNA repair activity
#46Carbonic anhydrase targeting agents and methods of using same
#47Methods Employing Mucin-Specific Proteases
#48COMPOSITIONS AND METHODS FOR IDENTIFYING SUBJECTS AT RISK FOR TRAUMATIC BRAIN INJURY
#49HIGH AFFINITY MONOCLONAL ANTIBODIES (MABS) AGAINST CELL SURFACE EXPRESSED HUMAN CARBONIC ANHYDRASE IX (HCA-IX), AND USES THEREOF
#50Peptide for treating rheumatoid arthritis and use thereof
#51PERSONALIZED CANCER IMMUNOTHERAPY
#52Antibodies against infectious diseases
#53CA IX-NIR dyes and their uses
#54METHODS OF DIAGNOSING A DISEASE AND METHODS OF MONITORING TREATMENT OF A DISEASE BY QUANTIFYING A NON-REDUCING END GLYCAN RESIDUAL COMPOUND AND COMPARING TO A SECOND BIOMARKER
#55DETECTION OF OLIGOSACCHARIDES
#56Methods for quantifying drug concentration in a prodrug composition
#57Minimally-invasive measurement of esophageal inflammation
#58Citrullinated peptides that bind to types of MHC class II and their use on diagnosis and treatment
#59METHODS FOR DIAGNOSING AND TREATING PROSTATE CANCER
#60MMP-8 AS A MARKER FOR IDENTIFYING INFECTIOUS DISEASE
#61CA IX—NIR dyes and their uses
#62CRYSTALLIZED OXALATE DECARBOXYLASE AND METHODS OF USE
#63Multi-protein biomarker assay for brain injury detection and outcome
#64Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof
#65Specific Increase of Dopamine Synthesis THrough Targeting of the Guanylate Cyclase 2C Receptor in the Treatment of Parkinson's Disease
#66Antibodies specific to alpha-enolase and uses thereof
#67ENOLASE 1 (ENO1) COMPOSITIONS AND USES THEREOF
#68Enolase 1 (ENO1) compositions and uses thereof
#69Carbonic anhydrase targeting agents and methods of using same
#70Blood diagnostics for evaluating and predicting brain damage after a concussion or other head injury
#71A NOVEL INVADOPODIA-SPECIFIC MARKER OF INVASIVE CANCER STEM CELLS AND THE USE THEREOF
#72Antibody binding to carbonic anhydrase and use thereof
#73COMPOSITIONS AND METHODS FOR IDENTIFYING SUBJECTS AT RISK FOR TRAUMATIC BRAIN INJURY
#74Minimally-invasive measurement of esophageal inflammation
#75Systems and methods for determining cyclic nucleotide concentration and related pathway activation
#76Predictive biomarker for hypoxia-activated prodrug therapy
#77Bacteria engineered to reduce hyperphenylalaninemia
#78Antibodies against infectious diseases
#79ENRICHMENT AND IDENTIFICATION OF FETAL MATERIAL
#80Methods for molecular classification of fatty liver by high-throughput protein post-translational modifications
#81Methods of diagnosing mucopolysaccharidosis (MPS) I and methods of monitoring treatment of MPS by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
#82CRYSTALLIZED OXALATE DECARBOXYLASE AND METHODS OF USE
#83CANCER DIAGNOSTIC COMPOSITION INCLUDING ANTIBODY FOR RIBOSOMAL PROTEIN S3, CANCER DIAGNOSTIC KIT INCLUDING THE SAME, AND METHOD OF PROVIDING INFORMATION ON CANCER DIAGNOSIS USING THE SAME
#84Fusion molecule based on TAA variant
#85Crystallized oxalate decarboxylase and methods of use
#86Carbonic anhydrase IX-specific antibodies and uses thereof
#87Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof
#88Detection of oligosaccharides
#89Compositions, methods and kits for diagnosis of lung cancer
#90VHH based binding antibodies for anthrax and botulinum toxins and methods of making and using therefor
#91Antibody binding to carbonic anhydrase and use thereof
#92Lanthanide toolbox for organelle specific molecular imaging
#93Artificial antigen produced using partial sequence of enolase protein originated from plasmodium falciparum, and method for producing same
#94CA IX—NIR dyes and their uses
#95COMPLIMENT FACTOR I BIOASSAY
#96COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER
#97COMPOSITIONS AND METHODS OF SELECTIVELY INHIBITING IRP1 AND TREATING INFLAMMATION
#98Method of detection of analyte active forms and determination of the ability of substances to bind into analyte active sites
#99Genetic signature of vulnerability to inhibitors of base excision repair (BER) in cancer
#100In vivo detection of proteins interaction based on adenylate cyclase hybrid system
#101NEURAL SPECIFIC S100-BETA FOR BIOMARKER ASSAYS AND DEVICES FOR DETECTION OF A NEUROLOGICAL CONDITION
#102Fusion molecule based on novel TAA variant
#103Minimally-invasive measurement of esophageal inflammation
#104SCHIFF-BASE CONJUGATE OF N, N-DIBUTYL-P-PHENYLENEDIAMINE WITH PYRIDOXAL 5'-PHOSPHATE FOR IMPROVED HOMOCYSTEINE ASSAYS USING PYRIDOXAL 5'-PHOSPHATE-DEPENDENT ENZYMES
#105Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
#106Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
#107Assay and method for quantitating carbonic anhydrase activity and assessing red blood hemolysis
#108MICROWELL PLATE FOR HIGH-THROUGHPUT DETECTION AND APPLICATION THEREOF
#109Methods of determining the presence, identity, and/or severity of mucopolysaccharidosis (MPS) VI and IVA
#110Liposomal detection devices and methods for their use and preparation
#111Method and system for determination of molecular interaction parameters
#112NANOSENSOR FOR DETECTING THE ACTIVITY OF GLYCOSAMINOGLYCAN-CLEAVING ENZYMES AND USES THEREOF
#113Multi-protein biomarker assay for brain injury detection and outcome
#114Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof
#115COLORIMETRIC ASSAY FOR L-GLUTAMINE AND RELATED ASSAY KIT
#116Assays for detection of phenylalanine ammonia-lyase and antibodies to phenylalanine ammonia-lyase
#117NOVEL ASSAY
#118Complexes of types of MHC class II that bind to collagen type II peptides and their use on diagnosis and treatment
#119Crystallized oxalate decarboxylase and methods of use
#120Compositions Having Dicamba Decarboxylase Activity and Methods of Use
#121Method of treating cancer by administering chimeric antigen receptor comprising anti-GCC antibody
#122Process for evaluating active agent(s) capable of preserving the functionality of epithelial stem cells
#123METHOD FOR DETECTING PYROPHOSPHATE BY MEANS OF BIOLUMINESCENCE DETECTION
#124Compositions and Methods For Analysis of C02 Absorption
#125Classifying a cancer disease using CAIX expression
#126Enzymes that cleave non-glycosidic ether bonds between lignins or derivatives thereof and saccharides
#127Enolase 1 (Eno1) compositions and uses thereof
#128Enolase 1 (Eno1) compositions and uses thereof
#129NERVE GROWTH INHIBITOR, CUTANEOUS-SENSORY-IRRITATION INHIBITOR, AND MARKER FOR CUTANEOUS-SENSORY-IRRITATION DETECTION
#130Methods for diagnosing and treating prostate cancer
#131IDENTIFICATION AND ERADICATION OF INSECT PESTS
#132Detection of oligosaccharides
#133Diagnosis and risk stratification of bladder cancer
#134PRE-SELECTION OF SUBJECTS FOR THERAPEUTIC TREATMENT WITH AN HSP90 INHIBITOR BASED ON HYPOXIC STATUS
#135SELECTIVE INHIBITION OF C4-PEP CARBOXYLASES
#136Alpha-enolase specific antibodies and methods of uses in cancer therapy
#137CANCER PROGNOSTIC ASSAYS
#138Method for evaluating ischemic heart disease by assaying complement factor H or D
#139Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#140BLOOD MARKER FOR RENAL CANCER
#141Compositions, methods and kits for diagnosis of lung cancer
#142Multiple biomarker set for breast cancer diagnosis, method of detecting the same, and diagnosis kit for breast cancer using antibody against the same
#143PREDICTIVE BIOMARKER FOR HYPOXIA-ACTIVATED PRODRUG THERAPY
#144Crystallized oxalate decarboxylase and methods of use
#145Collateral gene inactivation biomarkers and targets for cancer therapy
#146Method for evaluating the sensitivity and specificity of fast malaria-diagnosis test kits
#147Diagnostic methods
#148Antibiotic and anti-parasitic agents that modulate class II fructose 1,6-bisphosphate aldolase
#149Method for the determination of the concentration of vitamin B6 in a sample
#150Bioluminescent metal ion assay
#151Method of diagnosing Sjogren's disease
#152Enzymatic biosensing systems
#153Undercarboxylated/uncarboxylated osteocalcin increases beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decreases fat mass
#154Methods and kits that identify tumors responsive to Src inhibitors
#155Anti-GCC antibody molecules
#156Capillary electrophoresis method for fine structural analysis of enoxaparin sodium
#157Anti-GCC antibody molecules and methods for use of same
#158Fusion molecule based on novel TAA variant
#159ENZYME-LOGIC BIOSENSING
#160Method of diagnosing Sjogren's disease
#161Carbonic anhydrase targeting agents and methods of using same
#162Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#163Crystallized oxalate decarboxylase and methods of use
#164D-serine dehydratase and use thereof
#165Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
#166METHODS FOR PREDICTING OUTCOME IN TRAUMATIC BRAIN INJURY
#167Method for determining sensitivity to irinotecan and use thereof
#168Detection and treatment of schizophrenia
#169Methods to Distinguish Different Disaccharide Products after Digestion with Heparinases
#170CELL LINES EXPRESSING GUANYLATE CYCLASE-C AND METHODS OF USING THEM
#171MODIFIED HEPARINASE III AND METHODS OF SEQUENCING THEREWITH
#172BIOMARKERS FOR EARLY DIAGNOSIS OF SYSTEMIC TISSUE FIBROSIS
#173Method for identifying inhibitors of
#174METHODS AND KITS FOR DETERMINING A RISK TO DEVELOP CANCER, FOR EVALUATING AN EFFECTIVENESS AND DOSAGE OF CANCER THERAPY AND FOR CORRELATING BETWEEN AN ACTIVITY OF A DNA REPAIR ENZYME AND A CANCER
#175Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
#176ASSAYS FOR DETECTION OF PHENYLALANINE AMMONIA-LYASE AND ANTIBODIES TO PHENYLALANINE AMMONIA-LYASE
#177Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof
#178MN gene and protein
#179Method and system for determination of molecular interaction parameters
#180Methods for cyclic nucleotide determination
#181Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#182APEX AS A MARKER FOR LUNG CANCER
#183COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN
#184MOLECULES AND METHODS FOR TREATMENT OF DIABETES
#185Detection and treatment of schizophrenia
#186MN/CA IX and EGFR Pathway Inhibition
#187Marks as modifiers of the p53 pathway and methods of use
#188METHODS FOR PREDICTING OUTCOME IN TRAUMATIC BRAIN INJURY
#189Minimally-invasive measurement of esophageal inflammation
#190UNDERCARBOXYLATED/UNCARBOXYLATED OSTEOCALCIN INCREASES BETA-CELL PROLIFERATION, INSULIN SECRETION, INSULIN SENSITIVITY, GLUCOSE TOLERANCE AND DECREASES FAT MASS
#191D-SERINE DEHYDRATASE AND USE THEREOF
#192Detection of oligosaccharides
#193Fusion molecule based on novel TAA variant
#194Biomarkers for cancer sensitivity and uses thereof
#195Adenylyl cyclases as novel targets for antibactrial interventions
#196SCDs as modifiers of the p53 pathway and methods of use
#197Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds
#198Method for detecting pyrophosphate by means of bioluminescence detection
#199Methods for identifying or assaying for agents that increase beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decrease fat mass
#200Antigens and antibodies associated to pancreatic ductal adenocarcinoma
#201COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN
#202In Vitro Assay Based on Camp Levels Modulated by Gi-Coupled Receptors
#203Gene encoding a DNA repair enzyme and methods of use thereof
#204Distal tip of biosensor transducer comprising enzyme for deamination
#205Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#206Heparanase specific molecular probes and their use in research and medical applications
#207Modified heparinase III and methods of sequencing therewith
#208Enzymatic biosensors with enhanced activity retention for detection of organic compounds
#209Method of detecting metastasizing cancer cells originating in stomach cancer
#210Adenylyl cyclase antibodies, compositions and uses thereof
#211COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN
#212Method and system for determination of molecular interaction parameters
#213MN gene and protein
#214MN gene and protein
#215MARKs as Modifiers of the p53 Pathway and Methods of Use
#216Methods and compositions relating to anthrax pathogenesis
#217MN/CA IX and EGFR pathway inhibition
#218SCDs As Modifiers of the p53 Pathway and Methods of Use
#219Biomarkers for cancer sensitivity and uses thereof
#220Gene encoding a DNA repair enzyme and methods of use thereof
#221Crystallized oxalate decarboxylase and methods of use
#222Chemical inhibitors of soluble adenylyl cyclase (sAC)
#223Methods for predicting outcome in traumatic brain injury
#224Methods for cyclic nucleotide determination
#225Alpha-enolase specific antibody and method of use
#226Diagnostic and therapeutic use of the human sgpl1 gene and protein for neurodegenerative diseases
#227Tissue diagnostics for ovarian cancer
#228MN gene and protein
#229Compositions of low molecular weight heparin produced with modified heparinase III
#230Methods for preparing low molecular weight heparin with modified heparinase III
#231LIMKs as modifiers of p53 pathway and methods of use
#232Fluorescence polarization assay for determining histidine decarboxylase activity
#233Heparinase III and methods of specifically cleaving therewith
#234Methods for predicting outcome in traumatic brain injury
#235Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase
#236Polysaccharide conjugates of biomolecules
#237Heparinase III HLGAG fragments and uses thereof
#238Scintillation proximity assay method of measuring acetyl CoA carboxylase enzyme activity
#239Detection of CDX2 expression
#240Chds as modifiers of the p53 pathway and methods of use
#241Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#242Methods of renal cell carcinoma prognosis and treatment selection with carbonic anhydrase IX
#243Dgks as modifiers of the p53 pathwha and methods of use
#244Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#245Methods for the identification of inhibitors of porphobilinogen deaminase as antibiotics
#246Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds
#247Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
#248Method and system for determination of molecular interaction parameters
#249Compound embodiments for hydrogen sulfide production and methods of making and using the same
#250Compound embodiments for hydrogen sulfide production and methods of making and using the same
#251Gradient elution moving boundary electrophoresis for use with complex samples and detection of toxins
#252Modified biosensors and biocatalysts and methods of use
#253Gradient elution moving boundary electrophoresis for use with complex samples and detection of toxins
#254Anti-GCC antibody molecules and methods for use of same